No Data
No Data
Lake Street Maintains Augmedix(AUGX.US) With Buy Rating, Maintains Target Price $3.5
Lake Street analyst Brooks O'Neil maintains $Augmedix(AUGX.US)$ with a buy rating, and maintains the target price at $3.5.According to TipRanks data, the analyst has a success rate of 45.7% and a
William Blair Initiates Augmedix(AUGX.US) With Hold Rating
William Blair analyst Ryan Daniels initiates coverage on $Augmedix(AUGX.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 46.1% and a total average return of 6.4%
Wall Street Set to Open Flat Friday as Investors Eye Earnings Reports, FOMC Member Speeches
US stocks look set to open flat in Friday's trading session as investors take in a raft of earnings reports coming out, including those from American Express (AXP), Travelers Companies (TRV),
Lake Street Keeps Their Buy Rating on Augmedix (AUGX)
Sector Update: Health Care
Health care stocks were edging higher pre-bell Friday, with the Health Care Select Sector SPDR Fund (XLV) up 0.6% and the iShares Biotechnology ETF (IBB) advancing 0.2%.Augmedix (AUGX) shares were
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Friday as Global IT Outage Recovery Begins
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.2% and the actively traded Invesco QQQ Trust (QQQ) was 0.3% higher in Friday's premarket activity, as computer systems